modified directly observed therapy (mDOT)

BEHAVIORAL3 trials

Sponsors

University of Washington, Yale University, Phillip Coffin, MD, MIA

Conditions

Acquired Immunodeficiency SyndromeChronic Hepatitis CHepatitis COpiate Dependence

Phase 4

Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs

CompletedNCT02609893

Phillip Coffin, MD, MIAChronic Hepatitis C

Start: 2015-12-31End: 2019-08-31Updated: 2020-10-22

Unknown Phase

Longitudinal Study of HAART, Social Networks, & Adherence

CompletedNCT00272220

University of WashingtonAcquired Immunodeficiency Syndrome

Start: 2004-10-31End: 2006-06-30Updated: 2007-11-07

Effective Treatment of Hepatitis C in Substance Users

CompletedNCT00633243

Yale UniversityHepatitis C, Opiate Dependence

Start: 2007-04-30End: 2011-09-30Updated: 2013-01-03

Related Papers

Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs

PLoS ONE2019-06-0329 citations